Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors
Pantoflickova, D., Dorta, G., Ravic, M., Jornod, P., Blum, A. L.
Published in Alimentary pharmacology & therapeutics (15.06.2003)
Published in Alimentary pharmacology & therapeutics (15.06.2003)
Get full text
Journal Article
Phase II study of E7070 in patients with metastatic melanoma
Smyth, J. F., Aamdal, S., Awada, A., Dittrich, C., Caponigro, F., Schöffski, P., Gore, M., Lesimple, T., Djurasinovic, N., Baron, B., Ravic, M., Fumoleau, P., Punt, C. J. A.
Published in Annals of oncology (01.01.2005)
Published in Annals of oncology (01.01.2005)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of E7070, a Novel Chloroindolyl Sulfonamide Cell-Cycle Inhibitor, Administered as a One-Hour Infusion Every Three Weeks in Patients With Advanced Cancer
RAYMOND, E, TEN BOKKEL HUININK, W. W, TAÏEB, J, BEIJNEN, J. H, FAIVRE, S, WANDERS, J, RAVIC, M, FUMOLEAU, P, ARMAND, J. P, SCHELLENS, J. H. M
Published in Journal of clinical oncology (15.08.2002)
Published in Journal of clinical oncology (15.08.2002)
Get full text
Journal Article
Population Pharmacokinetics of the Novel Anticancer Agent E7070 During Four Phase I Studies: Model Building and Validation
VAN KESTEREN, Ch, MATHOT, R. A. A, WANDERS, J, BEIJNEN, J. H, FUMOLEAU, P, SCHELLENS, J. H. M, RAYMOND, E, ARMAND, J. P, DITTRICH, Ch, DUMEZ, H, ROCHE, H, DROZ, J. P, PUNT, C, RAVIC, M
Published in Journal of clinical oncology (01.10.2002)
Published in Journal of clinical oncology (01.10.2002)
Get full text
Journal Article
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)
Terret, C, Zanetta, S, Roché, H, Schellens, J.H.M, Faber, M.N, Wanders, J, Ravic, M, Droz, J.P
Published in European journal of cancer (1990) (01.05.2003)
Published in European journal of cancer (1990) (01.05.2003)
Get full text
Journal Article
Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Group (ECSG)
Punt, C. J. A., Fumoleau, P., van de Walle, B., Faber, M. N., Ravic, M., Campone, M.
Published in Annals of oncology (01.09.2001)
Published in Annals of oncology (01.09.2001)
Get full text
Journal Article
Safety and efficacy of 7‐day rabeprazole‐ and omeprazole‐based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease
Hawkey, C. J., Atherton, J. C., Treichel, H. C., Thjodleifsson, B., Ravic, M.
Published in Alimentary pharmacology & therapeutics (01.04.2003)
Published in Alimentary pharmacology & therapeutics (01.04.2003)
Get full text
Journal Article
The effects of chronic, dose-dependent administration of dronedarone and amiodarone on cardiodynamics and oxidative stress parameters of isolated rat heart with hypertension
Simovic, S, Jeremic, J, Srejovic, I, Davidovic, G, Zivkovic, V, Mitrovic, S, Nikolic, M, Ravic, M, Andjic, M, Rankovic, M, Draginic, N, Jakovljevic, V
Published in Europace (London, England) (19.05.2022)
Published in Europace (London, England) (19.05.2022)
Get full text
Journal Article
In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood
Bongard, H J G D van den, Pluim, D, Waardenburg, R C A M van, Ravic, M, Beijnen, J H, Schellens, J H M
Published in Anti-cancer drugs (01.07.2003)
Published in Anti-cancer drugs (01.07.2003)
Get more information
Journal Article
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N‐(3‐chloro‐7‐indolyl)‐1,4‐benzenedisulphonamide)
Van Kesteren, Charlotte, Mathôt, R. A. A., Raymond, E., Armand, J. P., Fumoleau, P., Punt, C., Ravic, M., Wanders, J., Beijnen, J. H., Schellens, J. H. M.
Published in British journal of clinical pharmacology (01.11.2002)
Published in British journal of clinical pharmacology (01.11.2002)
Get full text
Journal Article
P561Acute effects of dronedarone and amiodarone on functional, morphological and oxidative stress parameters in isolated rat heart with hypertension
Simovic, S, Jeremic, J, Davidovic, G, Srejovic, I, Mitrovic, S, Zivkovic, V, Ravic, M, Miloradovic, V, Nikolic, M, Vucic, R, Andjic, M, Rankovic, M, Draginic, N, Jakovljevic, V
Published in Europace (London, England) (01.06.2020)
Published in Europace (London, England) (01.06.2020)
Get full text
Journal Article
The dose-dependent effect of chronic Verapamil treatment on cardiac function in isolated rat heart with Hypertension
Simovic, S, Jeremic, J, Davidovic, G, Srejovic, I, Zivkovic, V, Ravic, M, Nikolic, M, Iric-Cupic, V, Vucic, R, Sreckovic, M, Miloradovic, V, Andjic, M, Rankovic, M, Draginic, N, Jakovljevic, V
Published in Europace (London, England) (24.05.2021)
Published in Europace (London, England) (24.05.2021)
Get full text
Journal Article
Population pharmacokinetics and pharmacokinetic‐pharmacodynamic relationships of the novel anticancer agent E7070 in four phase I studies
Van Kesteren, CH, Mathôt, R. A. A., Raymond, E., Armand, J. P., Dittrich, CH, Dumez, H., Roché, H., Droz, J. P., Punt, C., Ravic, M., Wanders, J., Beijnen, J. H., Fumoleau, P., Schellens, J. H. M.
Published in British journal of clinical pharmacology (01.05.2002)
Published in British journal of clinical pharmacology (01.05.2002)
Get full text
Journal Article
700 Results of a phase-1 dose escalation study of intravesical TMX-101 in patients with non-muscle invasive bladder cancer
Falke, J, Lammers, J.M, Arentsen, H.C, Ravic, M, Pozzi, R, Cornel, E.B, Vergunst, H, De Reijke, T.M, Witjes, J.A
Published in European urology supplements : official journal of the European Association of Urology (01.03.2013)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2013)
Get full text
Journal Article
5,6-Dimethylxanthenone-4-Acetic Acid in the Treatment of Refractory Tumors: a Phase I Safety Study of a Vascular Disrupting Agent
MCKEAGE, Mark J, FONG, Peter, JEFFERY, Mark, BAGULEY, Bruce C, KESTELL, Phil, RAVIC, Miroslav, JAMESON, Michael B
Published in Clinical cancer research (15.03.2006)
Published in Clinical cancer research (15.03.2006)
Get full text
Journal Article
1072P - Recruit-Tandab AFM13 - Overcoming Limitations of Monoclonal Antibodies in Hodgkin Lymphoma
Zhukovsky, E., Ravic, M., Rothe, A., Topp, M., Younes, A., Knackmuss, S., Reusch, U., Rajkovic, E., Hucke, C., Little, M.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Recruit-Tandab AFM13 - Overcoming Limitations of Monoclonal Antibodies in Hodgkin Lymphoma
Zhukovsky, E., Ravic, M., Rothe, A., Topp, M., Younes, A., Knackmuss, S., Reusch, U., Rajkovic, E., Hucke, C., Little, M.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article